Torii Pharmaceutical Co Ltd (4551)

Tokyo
Currency in JPY
5,070.0
+130.0(+2.63%)
Closed
4551 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week High
Fair Value
Day's Range
4,930.05,110.0
52 wk Range
3,105.05,110.0
Key Statistics
Edit
Bid/Ask
5,060.00 / 5,080.00
Prev. Close
4,940
Open
4,940
Day's Range
4,930-5,110
52 wk Range
3,105-5,110
Volume
167.8K
Average Volume (3m)
123.79K
1-Year Change
33.51%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4551 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
4,485.0
Downside
-11.54%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Torii Pharmaceutical Co Ltd Company Profile

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents for renal diseases and hemodialysis, such as ENAROY tablets to treat anemia associated with CKD; Riona tablets for the treatment of hyperphosphatemia/iron deficiency anemia (IDA); and REMITCH, an oral therapeutic agent for the treatment of pruritus. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; CORECTIM, a topical janus kinase (JAK) inhibitor; VTAMA cream, a topical treatment for atopic dermatitis and plaque psoriasis; and allergen immunotherapy tablets comprising CEDARCURE and MITICURE. It markets its products primarily through medical representatives for medical professionals. The company has a collaboration with ALK-Abelló A/S to develop and commercializes ALK’s allergen immunotherapy drug targeting pollen diseases caused by grass pollen. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.

Employees
583
Market
Japan

Compare 4551 to Peers and Sector

Metrics to compare
4551
Peers
Sector
Relationship
P/E Ratio
27.0x2.5x−0.6x
PEG Ratio
0.500.020.00
Price/Book
1.2x1.1x2.6x
Price / LTM Sales
2.4x1.7x3.1x
Upside (Analyst Target)
−9.5%8.2%53.1%
Fair Value Upside
Unlock7.7%7.5%Unlock

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 4,485.0
(-11.54% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 187.7
Dividend Yield
2.43%
Industry Median 2.28%
Annualised payout
120
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Oct 31, 2024
EPS / Forecast
46.39 / --
Revenue / Forecast
15.02B / --
EPS Revisions
Last 90 days

FAQ

What Is the Torii Pharmaceutical (4551) Stock Price Today?

The Torii Pharmaceutical stock price today is 5,070.00

What Stock Exchange Does Torii Pharmaceutical Trade On?

Torii Pharmaceutical is listed and trades on the Tokyo stock exchange.

What Is the Stock Symbol for Torii Pharmaceutical?

The stock symbol for Torii Pharmaceutical is "4551."

Does Torii Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?

The Torii Pharmaceutical dividend yield is 2.37%.

What Is the Torii Pharmaceutical Market Cap?

As of today, Torii Pharmaceutical market cap is 142.33B.

What is Torii Pharmaceutical Earnings Per Share?

The Torii Pharmaceutical EPS is 187.70.

What Is the Next Torii Pharmaceutical Earnings Date?

Torii Pharmaceutical will release its next earnings report on 06 Feb 2025.

From a Technical Analysis Perspective, Is 4551 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.